Podcast
Questions and Answers
Which is not a goal of therapy for Immune-Mediated Polyarthritis (IMPA)?
Which is not a goal of therapy for Immune-Mediated Polyarthritis (IMPA)?
- Resolution of inflammation
- Promotion of muscle mass reduction (correct)
- Supportive care
- Pain control
What is the hallmark of Immune-Mediated Polyarthritis (IMPA) in synovial fluid analysis?
What is the hallmark of Immune-Mediated Polyarthritis (IMPA) in synovial fluid analysis?
- Septic synovial fluid
- Suppurative synovial fluid
- Lymphocytic synovial fluid (correct)
- Clear synovial fluid
Which medication is commonly used for Immune-Mediated Polyarthritis (IMPA) treatment, but can lead to muscle mass reduction and increased ligament laxity in large/giant breed dogs?
Which medication is commonly used for Immune-Mediated Polyarthritis (IMPA) treatment, but can lead to muscle mass reduction and increased ligament laxity in large/giant breed dogs?
- NSAIDs
- Mycophenolate
- Prednisone (correct)
- Cyclosporine
Which agents have shown promise in achieving remission in Immune-Mediated Polyarthritis (IMPA) cases as adjunctive therapy?
Which agents have shown promise in achieving remission in Immune-Mediated Polyarthritis (IMPA) cases as adjunctive therapy?
What is an appropriate choice as a second agent to prednisone therapy in Immune-Mediated Polyarthritis (IMPA) cases?
What is an appropriate choice as a second agent to prednisone therapy in Immune-Mediated Polyarthritis (IMPA) cases?
What is a reliable marker for monitoring IMPA, as it correlates with joint fluid cellularity and joint mobility, and decreases with treatment efficacy?
What is a reliable marker for monitoring IMPA, as it correlates with joint fluid cellularity and joint mobility, and decreases with treatment efficacy?
What is important for managing IMPA during the initial treatment phase?
What is important for managing IMPA during the initial treatment phase?
What type of synovial fluid is not a hallmark of Immune-Mediated Polyarthritis (IMPA)?
What type of synovial fluid is not a hallmark of Immune-Mediated Polyarthritis (IMPA)?
Which medication can be used for anti-inflammatory and analgesic support in Immune-Mediated Polyarthritis (IMPA) cases where steroids are not suitable?
Which medication can be used for anti-inflammatory and analgesic support in Immune-Mediated Polyarthritis (IMPA) cases where steroids are not suitable?
What involves gross and cytologic analysis including color, turbidity, viscosity, protein, cell count, and cytology?
What involves gross and cytologic analysis including color, turbidity, viscosity, protein, cell count, and cytology?
What is a potential consequence of high steroid doses in large/giant breed dogs during Immune-Mediated Polyarthritis (IMPA) treatment?
What is a potential consequence of high steroid doses in large/giant breed dogs during Immune-Mediated Polyarthritis (IMPA) treatment?
Which type of Immune-Mediated Polyarthritis (IMPA) is the most common?
Which type of Immune-Mediated Polyarthritis (IMPA) is the most common?
What is the hallmark of Immune-Mediated Polyarthritis (IMPA) in synovial fluid analysis?
What is the hallmark of Immune-Mediated Polyarthritis (IMPA) in synovial fluid analysis?
What is a potential consequence of high steroid doses in large/giant breed dogs during Immune-Mediated Polyarthritis (IMPA) treatment?
What is a potential consequence of high steroid doses in large/giant breed dogs during Immune-Mediated Polyarthritis (IMPA) treatment?
What involves gross and cytologic analysis including color, turbidity, viscosity, protein, cell count, and cytology?
What involves gross and cytologic analysis including color, turbidity, viscosity, protein, cell count, and cytology?
Which medication is commonly used for Immune-Mediated Polyarthritis (IMPA) treatment, but can lead to muscle mass reduction and increased ligament laxity in large/giant breed dogs?
Which medication is commonly used for Immune-Mediated Polyarthritis (IMPA) treatment, but can lead to muscle mass reduction and increased ligament laxity in large/giant breed dogs?
Which is not a cause of Immune-Mediated Polyarthritis (IMPA)?
Which is not a cause of Immune-Mediated Polyarthritis (IMPA)?
What is a reliable marker for monitoring IMPA, as it correlates with joint fluid cellularity and joint mobility, and decreases with treatment efficacy?
What is a reliable marker for monitoring IMPA, as it correlates with joint fluid cellularity and joint mobility, and decreases with treatment efficacy?
What is important for managing IMPA during the initial treatment phase?
What is important for managing IMPA during the initial treatment phase?
Which medication can be used for anti-inflammatory and analgesic support in Immune-Mediated Polyarthritis (IMPA) cases where steroids are not suitable?
Which medication can be used for anti-inflammatory and analgesic support in Immune-Mediated Polyarthritis (IMPA) cases where steroids are not suitable?
Which agents have shown promise in achieving remission in Immune-Mediated Polyarthritis (IMPA) cases as adjunctive therapy?
Which agents have shown promise in achieving remission in Immune-Mediated Polyarthritis (IMPA) cases as adjunctive therapy?
What type of synovial fluid is not a hallmark of Immune-Mediated Polyarthritis (IMPA)?
What type of synovial fluid is not a hallmark of Immune-Mediated Polyarthritis (IMPA)?
What is a potential consequence of high steroid doses in large/giant breed dogs during Immune-Mediated Polyarthritis (IMPA) treatment?
What is a potential consequence of high steroid doses in large/giant breed dogs during Immune-Mediated Polyarthritis (IMPA) treatment?
Study Notes
Immune-Mediated Polyarthritis in Dogs: Diagnosis and Treatment
- Differential diagnosis for joint taps includes ruling out secondary causes such as infectious bacterial, fungal, and neoplastic conditions
- Synovial fluid analysis involves gross and cytologic analysis including color, turbidity, viscosity, protein, cell count, and cytology
- Non-septic, suppurative, or lymphocytic synovial fluid is the hallmark of Immune-Mediated Polyarthritis (IMPA)
- Goals of therapy for IMPA involve resolution of inflammation, pain control, and supportive care
- Steroids are commonly used for IMPA treatment, but high doses in large/giant breed dogs can lead to muscle mass reduction and increased ligament laxity
- Adjunctive agents such as leflunomide and cyclosporine have shown promise in achieving remission in IMPA cases
- NSAIDs, tramadol, and gabapentin can be used for anti-inflammatory and analgesic support in cases where steroids are not suitable
- Cyclosporine, mycophenolate, azathioprine, and leflunomide are appropriate choices as second agents to prednisone therapy
- Neuropathic pain medications and NMDA antagonists can be used for pain management in IMPA cases
- Hydration support and limiting activity during the initial treatment phase are important for managing IMPA
- Monitoring IMPA involves repeat joint taps, considering plasma C-Reactive Protein, and assessing clinical signs for remission
- Plasma C-Reactive Protein is a reliable marker for monitoring IMPA, as it correlates with joint fluid cellularity and joint mobility, and decreases with treatment efficacy
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
Test your knowledge on the diagnosis and treatment of Immune-Mediated Polyarthritis (IMPA) in dogs with this informative quiz. Explore differential diagnosis, synovial fluid analysis, therapy goals, treatment options, monitoring, and more.
